Organs are composites of tissue types with diverse developmental origins, and they rely on distinct stem and progenitor cells to meet physiological demands for cellular production and homeostasis. How diverse stem cell activity is coordinated within organs is not well understood. Here we describe a lineage-restricted, self-renewing common skeletal progenitor (bone, cartilage, stromal progenitor; BCSP) isolated from limb bones and bone marrow tissue of fetal, neonatal, and adult mice. The BCSP clonally produces chondrocytes (cartilage-forming) and osteogenic (bone-forming) cells and at least three subsets of stromal cells that exhibit differential expression of cell surface markers, including CD105 (or endoglin), Thy1 [or CD90 (cluster of differentiation 90)], and 6C3 [ENPEP glutamyl aminopeptidase (aminopeptidase A)]. These three stromal subsets exhibit differential capacities to support hematopoietic (blood-forming) stem and progenitor cells. Although the 6C3-expressing subset demonstrates functional stem cell niche activity by maintaining primitive hematopoietic stem cell (HSC) renewal in vitro, the other stromal populations promote HSC differentiation to more committed lines of hematopoiesis, such as the B-cell lineage. Gene expression analysis and microscopic studies further reveal a microenvironment in which CD105-, Thy1-, and 6C3-expressing marrow stroma collaborate to provide cytokine signaling to HSCs and more committed hematopoietic progenitors. As a result, within the context of bone as a blood-forming organ, the BCSP plays a critical role in supporting hematopoiesis through its generation of diverse osteogenic and hematopoietic-promoting stroma, including HSC supportive 6C3(+) niche cells.
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endochondral ossification | lymphopoiesis T he postnatal mammalian bone marrow compartment is the site of hematopoiesis and osteogenesis. It consists of cells of osteoid, cartilaginous, and hematopoietic lineages, as well as hematopoietic "niche" cells. This niche, or microenvironment, contains diverse cell types that, with their secreted products, are required by hematopoietic stem cells (HSCs) to generate the full array of blood and immune cells (1, 2) . The cellular constitution of niches is poorly understood but is believed to include osteoblasts, endothelial cells, glial cells, vascular pericytes, adipocytes, fibroblasts, and nestinexpressing mesenchymal stromal cells (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . The existence of HSC niches is substantiated by evidence that HSCs continuously enter and exit the bone marrow from the peripheral circulation and that direct HSC transplants engraft in numbers that correlate with the number of HSCs in circulation (14, 15) .
Although the hematopoietic progenitors and lineages in bone marrow have been isolated and functionally characterized, much less is known about the nonhematopoietic lineages that compose the HSC niche in bone marrow. In this study, we used a reductionist approach to isolating and characterizing the nonhematopoietic cell types that constitute the bone marrow microenvironment (16) . Using fluorescent activated cell sorting (FACS), we divided a crude postnatal limb bone and bone marrow suspension from actin-green fluorescent protein (GFP) mice into distinct fractions. We assessed these fractions by transplanting them under the renal capsule in immunodeficient mice and following their growth. As a result, we identified four functionally distinct fractions: a CD45+ hematopoietic fraction, a CD45-Tie2 (angiopoietin receptor)+alpha V integrin (alphaV)+ population that concurrently generates adipocytes and vessels, a CD45-Tie2-alphaV-fraction that does not appear to produce donor-engrafted tissue, and a CD45-Tie2-alphaV+ population that, through endochondral ossification, forms bone containing robust marrow ( Fig. 1 A-D and SI Appendix, Fig. S1 ) (17) . In the marrow cavity of these extraskeletal bones, the cells labeled with CD45-Tie2-alphaV+ GFP+ contributed substantially to the stromal compartments (Fig. 1E) . When mice harboring these GFP-labeled extraskeletal bones were irradiated and received transplants of red fluorescent protein (RFP) HSCs, the newly transplanted HSCs homed to the GFP-labeled stromal cells in the marrow cavity. This finding indicates that the progenitors of the stromal niche were also contained within the osteoblast and chondrocyte-generating CD45-Tie2-alphaV+ transplanted population (Fig. 1F) . CD45-Tie2-alphaV+ cells from bones invariably formed ectopic bones complete with marrow cavities when transplanted into various forms of extraskeletal mesenchymal tissue, including fat, lung, and striated muscle, instead of differentiating into the cell types of their surrounding microenvironment ( Fig. 1 G-J and SI Appendix, Fig. S2 ). Unfractionated skeletal stromal cells also formed ectopic bones when transplanted into the heart. These data suggest that tissue progenitors in the bone and bone marrow are predetermined to develop into distinct tissue lineages such as osteoblasts and endothelial cells. Therefore, the specific differentiation capability of each stromal The authors declare no conflict of interest. 1 C.K.F.C., P.L., and W.J. contributed equally to this work. 2 To whom correspondence may be addressed. E-mail: chazchan@stanford.edu, longaker@ stanford.edu, or irv@stanford.edu.
subset must be functionally evaluated before clinical use; for instance, in the treatment of cardiac disease (18) .
Because the extraskeletal transplantation of the skeletogenic CD45-Tie2-alphaV+ progenitor population generated multiple lineages (including cartilaginous, stromal, and osteoid), we screened additional surface markers by FACS to determine whether the subpopulations within this stromal fraction are separate or linked tissue lineages (19) . FACS analysis of mouse limb progenitors at progressive stages of development (fetal, newborn, and adult) indicated that CD105 is an early marker of skeletal lineage commitment and is detectable as early as embryonic stage 13 (E13) days post coitus (dpc) in mice. In contrast, Thy1 is expressed later, at E15, during the onset of osteogenesis. Finally, 6C3 appears at E17, corresponding to the transition of fetal liver/ spleen hematopoiesis to bone marrow hematopoiesis (SI Appendix, Fig. S3 ) (20, 21) .
On the basis of these observations, we then fractionated CD45-Tie2-alphaV+ skeletal progenitors by differential expression of CD105, Thy1, and 6C3 and transplanted individual subsets under the renal capsule to evaluate their potential for in vivo differentiation ( Fig. 2 A-F) . GFP-labeled Thy1+ and 6C3+ cells universally formed ectopic bones 1 mo after implantation, indicating that they are restricted to osteogenic lineages. Immunostaining of the perivascular and stromal components of adult bone marrow also demonstrated the presence of Thy1+ and 6C3+ subpopulations, suggesting these cells play a role in maintenance of adult skeletal tissue (SI Appendix, Fig. S4 ). Notably, both Thy1+ and 6C3+ subsets, when transplanted, could only form bones without marrow cavities ( Fig. 2 D-F) . In contrast, the CD105+Thy1−6C3− subset could initiate formation of ectopic bones with marrow cavities containing functional HSCs, via endochondral ossification (bone formation through a cartilaginous intermediate) (Fig. 2C) . The ectopic bones formed by CD105+Thy1−6C3− progenitors also contained Thy1+ and 6C3+ subsets ( Fig. 2C and SI Appendix, Fig.  S5 ). These findings indicate that bone, chondrocytes, and multiple types of osteogenic stroma are all commonly derived from CD105 +Thy1−6C3− skeletal progenitors (22, 23) .
To determine whether the CD105+Thy1−6C3− bone, cartilage, stromal progenitor (BCSP) subset is a heterogeneous population of separate chondrocyte-restricted and osteogenicrestricted progenitors, we assayed the differentiation potential of single BCSPs. Our data indicate that single BCSPs are multipotent and capable, at the single-cell level, of generating in vitro colonies containing collagen type 2-expressing chondrocytes and osteocalcin-expressing osteoblasts ( Fig. 2 G-I) . The multipotency of BCSPs is also evident in vivo when single GFPlabeled BCSPs are transplanted with 5,000 unsorted non-GFP skeletal progenitors as supportive feeders (Fig. 2, Bottom) . BCSPs transplanted in this fashion formed ectopic bones containing regions in which BCSP-derived cells differentiated into chondrocytes, osteoblasts, and stromal cells ( Fig. 2 J-O) . These data support the conclusion that the BCSP is the developmental branch point at which commitment to chondrocyte, bone, or stromal fates is determined.
With the BCSP as our starting point, we tested the hypothesis that the mechanisms through which the BCSP initiates niche formation also include generation of hematopoietic supportive stromal cells. There has been much speculation as to the nature and origin of hematopoietic supportive stroma. Several bone marrow-derived stromal lines such as OP9, S17, and AC6.21 can support in vitro maintenance and differentiation of hematopoietic progenitors. Of these, AC6.21 is uniquely capable of supporting both early myeloerythropoiesis and long-term (blue dots) and CD105(+)6C3(+) (green dots) were reisolated and plated with 250 freshly isolated HSCs in serum-free media containing SCF, thrombopoietin (TPO), insulin-like growth factor 1 (IGF1), and fibroblast growth factor 2 (FGF2) (purple dots are neither Thy1+ nor 6C3+). After 10 d, the cocultures were transplanted into lethally irradiated congenic recipients. Donor granulocyte chimerism was measured in the peripheral blood 5, 10, and 20 wk after transplantation. (C) Three mice were analyzed per group, and the results were averaged. Freshly sorted HSCs were transplanted for comparison. Only HSCs cocultured with CD105(+)6C3(+) stroma gave levels of engraftment comparable to the fresh HSC transplants. *P < 0.05 by ANOVA; **P < 0.0001 by ANOVA.
lymphopoiesis, suggesting it may be capable of supporting multipotent hematopoietic stem/progenitors such as HSCs (24) (25) (26) . Indeed, a derivative of AC6.21 appears to be capable of supporting expansion of human HSCs in vitro (26) (27) (28) (29) (30) . Although its exact cellular origin remains unknown, the AC6.21 clonal cell-line was originally established from long-term Whitlock-Witte bone marrow cultures. It is also characterized by its expression of cell surface 6C3/BP-1 antigen, an aminopeptidase expressed by early B-cell progenitors and mouse B-cell lymphomas (31-33) (SI Appendix, Fig. S3 ). Because we have also observed a BCSP-derived stromal subset that is 6C3+, we tested the ability of distinct 6C3+ and Thy1+ osteogenic stromal populations derived from BCSPs to support hematopoiesis ( Fig. 3 A-C) . We cultured freshly isolated BCSPs in vitro for 3 wk to allow for differentiation and then reisolated three distinct lineages based on CD105, Thy1, and 6C3 expression: CD105+Thy1−6C3− cells that likely represent selfrenewing BCSPs (and thus are candidate stem cells), CD105+ Thy1−6C3+ stroma, and CD105+Thy1+6C3− osteoblast progenitors. We then cocultured each population with HSCs in serum-free conditions with the addition of four cytokines: steel factor, thrombopoietin, insulin-like growth factor, and fibroblast growth factor (34) . After 10 d of coculture, we retransplanted cocultured HSCs into lethally irradiated mice to determine whether they could still functionally reconstitute multilineage hematopoiesis [ Fig. 3C and SI Appendix, Figs. S6 (diagram) and S7] (35-37). We observed that 6C3+ stroma strongly promoted survival and maintenance of multilineage reconstitution by HSC, similar to AC6.2.1 cells. Indeed, the CD105+Thy1−6C3+ stromal cell was likely the source of the original AC6.2.1 line. (Ironically, we have, by reductionist approaches to bone and bone marrow formation, apparently rediscovered the clonal stromal cell originally isolated by us in the mid-1980s.) In contrast, there was little or no engraftment by HSCs cultured without stroma under these minimal conditions. We also observed comparatively low engraftment by Thy1+ cells, indicating that 6C3+ stroma are uniquely capable of maintaining HSCs and therefore possess functional HSC niche activity at least in vitro ( Fig. 3C and SI Appendix, Fig. S7 ). On the basis of our data, engineering combinations of 6C3+ stroma, cytokines, and possibly stromal cells of other tissue origins such as endothelium could be the key to longterm in vitro maintenance and/or expansion of HSCs.
We next explored the mechanisms by which 6C3+ stroma affect the endogenous HSC niche. To determine whether direct interaction with 6C3+ stroma facilitates HSC engraftment, we transplanted RFP-labeled HSCs and studied their association with stromal cells in situ by immunofluorescence (additional details in Materials and Methods). Nearly all detected HSCs were within one-cell distance of 6C3+ expressing stroma ( Fig. 4A and SI Appendix, Fig. S8) . Surprisingly, these HSC were also simultaneously associated with Thy1+ stroma, suggesting that HSC niches are multicellular entities composed of distinct types of hematopoiesis supporting stromal cells. Because other stromal cell types, including nestin-expressing cells, have recently been reported to associate with HSCs in the bone marrow, we conducted further immunofluorescent microscopy experiments to determine the location of 6C3+ and Thy1+ stroma relative to nestin-expressing cells. Contrary to our expectations, both 6C3+ and Thy1+ stroma expressed nestin (SI Appendix, Fig. S9-S11 ). In fact, nestin did not appear to be a specific marker for stromal cells, as we observed that nestin expression spans many types of tissues, both mature and immature, in bone marrow and other tissues (SI Appendix, Fig. S12 ) (38) (39) (40) (41) (42) (43) .
To understand the genetic mechanisms underlying niche function and formation, we conducted mRNA gene expression analysis on highly purified BCSP and BCSP-derived 6C3+ and Thy1+ stroma (Fig. 4B ). In agreement with our extraskeletal transplantation studies, we found that although each of these populations expresses high levels of osteonectin (a bone lineageassociated marker), transcripts of other mesenchymal lineages such as muscle, endothelium, and adipose tissue were not detected. These data suggest that the skeletal-lineage commitment of BCSP, 6C3+, and Thy1+ cells is already primed and regulated at the transcriptional level. The BCSP populations also express very high levels of the master regulator genes osterix and runt-related transcription factor 2 (runx2), which are possibly portions of the transcriptional machinery necessary for specifying skeletal and stromal fates. In addition, it is the Thy1+ subset that expresses many of the known cytokines and adhesion proteins involved in engraftment and maintenance of hematopoietic progenitors, including stem cell (steel) factor (SCF), stromal derived factor, angiopoietin, endothelial cell-selective adhesion molecule (Esam), and slit homolog 2 protein (slit2) (44) (45) (46) (47) (48) . These cytokines and membrane proteins also possess corresponding cognate receptors on HSCs.
Despite this transcriptional profile, Thy1+ stroma did not by themselves support hematopoiesis in our experiments (Fig. 3C) . In contrast, the functionally supportive 6C3+ subset expressed very little of these factors, indicating that 6C3+ stromal cells expresses factors that remain unknown but are required for HSC maintenance. Because no single stromal subset expresses all of the necessary factors for maintaining HSC niches based on transcriptional profile, niches are likely composed of multiple stromal types that act in concert to support hematopoiesis. Similarly, in clonal BCSP-derived stromal colonies, only colonies that contained both Thy1+ and 6C3+ stroma could maintain HSCs in vitro (Fig. 4 C-E) . Therefore, multiple HSC-supportive stromal types in the niche are derived from BCSP.
Although we focused on stromal cells and their relation to HSC maintenance, we also observed additional BCSP-derived lineages that support more committed hematopoietic progenitors (49) (50) . For example, an additional CD105-Thy1+6c3− stromal lineage derived from BCSPs appears to support or direct B-lymphopoiesis exclusively (SI Appendix, Fig. S6 ). This leads us to propose a model for hematopoietic niches in which supportive environments for distinct types of primitive hematopoietic progenitors, including HSCs, are composed primarily of multiple BCSP-derived stromal types (Fig. 5) . Future studies on the genetic mechanisms underlying fate selection by BCSPs could reveal the cytokine composition of molecular programs that regulate specific types of hematopoiesis through skeletogenesis (51) .
We observed that the experimental formation of bone, cartilage, and bone marrow by BCSPs attracts HSCs and vasculogenesis and appears to properly regulate hematopoiesis. The similarity between these experimental processes and endogenous processes provides evidence that the generation of the marrow involves a complex set of architectural domain constructions, as in the most complex of other tissues. This realization should further enable the study of the cellular, gene expression, and cell migration events important to hematopoiesis. The formation of an HSC niche and a B lineage niche via distinct stroma may indicate that many other niche microdomains regulating granulopoiesis, monocytopoiesis, megakaryopoiesis, and erythropoiesis exist, consist of their own stroma, and are perhaps derived from the BCSP (48) . In addition, the migration of HSCs from yolk sac blood islands to aorta-gonadmesonephros to fetal liver to spleen all involve formation, and perhaps later dissolution, of nonskeletogenic hematopoietic niches. Thus, the precise definition of niche populations, their developmental origin, and their relation to the bone-containing BCSP is crucial to understanding normal and pathogenic hematopoiesis (53-56).
Materials and Methods
See SI Appendix, Materials and Methods for full materials and methods.
Mice. C57BL/K a -Thy1.1-CD45.1, C57BL/K a -Thy1.1-CD45.1 (BA), C57BL/K a -Thy1.2-CD45.1, and C57BL/K a -Thy1.2-CD45.1-actin GFP, and rosa26-mRFP (C57BL/6 [B6]) strains were derived and maintained in our laboratory. All animals were maintained in Stanford University Laboratory Animal Facility in accordance with Stanford Animal Care and Use Committee and National Institutes of Health guidelines.
Isolation and Transplantation of Adult and Fetal Skeletal Progenitors.
Fetal skeletal elements (humerus, radius, tibia, femur, and pelvis) were dissected from C57/BL6 BA strain fetuses and digested in collagenase with DNase at 37°C for 40 min under constant agitation. Sorted and unsorted skeletal progenitors were pelleted and resuspended in 2 mL matrigel (regular) and then injected underneath the renal capsule of 8-to 12-wk-old anesthetized mice.
HSC-Stromal Coculture and Transplant. To establish stromal populations for HSC coculture experiments, 200,000 CD105+Thy1-6C3-CD45-Tie2-alphaV+ BCSPs were fresh-sorted from dissociated bone and bone marrow stroma of e15.5 dpc, e17.5 dpc, or newborn (postnatal day 0-3) mice and plated on 0.1% (vol/vol) gelatin-coated 15-cm culture dish and supported with MEMalpha medium supplemented with 20% FCS and PenStrep (Invitrogen) antibiotic. Two weeks after culture, cells were lifted by incubating with M199 medium supplemented with Collagenase II at 1 mg/mL and then stained and FACssorted for indicated populations. Then 250 fresh-sorted HSCs were added to the stromal cells and cocultured in StemPro serum-free stem cell culture media supplemented with 10 ng/mL mouse recombinant steel factor (Peprotech), 5 ng/mL mouse recombinant Thrombopoietin (Peprotech), 20 ng/ mL basic fibroblast growth factor (R&D), and 25 ng/mL insulin growth factor (R&D). Culture medium was changed by removing and replacing half of it with fresh medium every other day for 10 d. On the tenth day, cells were removed for analysis and or transplanted to irradiated mice. For HSC transplants, the contents of each well corresponding to ∼250 plated HSCs were combined with 300,000 unsorted host bone marrow cells as helper marrow and injected retro-orbitally into lethally irradiated (800 rad) congenic mice. Engraftment was assessed by FACS analysis of tail blood samples collected at 5-, 10-, and 15-wk intervals for analysis of expression of congenic CD45.1 or CD45.2 and blood lineage-specific markers (i.e., B-cell (B220+CD3−), Tcell (CD3+B220−), and granulocyte [B220-CD3-Gr1hi-ssc(hi)] markers).
Microarray Analyses of BM Stromal Progenitors. We performed microarrays on BCSPs, Thy1+ cells, 6C3+ cells, and B-cell lymphocyte stimulating populations (BLSPs). Each population was sorted in three independent sorts from limbs from 3-to 5-d-old male neonates. RNA was isolated with RNeasy Micro Kit (Qiagen) per manufacturer's instructions. mRNA amplification was performed using a two-cycle target labeling system for 3′ in vitro transcription, hybridized to a mouse genome 430 2.0 array, and scanned according to the manufacturer's protocol (Affymetrix). Background correction and signal normalization was performed using the standard multichip average algorithm (54-55). For transplantation of adult limb bones (humerus, radius, tibia, femur, and pelvis) the same process was used as described in the previous paragraph, except the bones were gently crushed with a mortar and pestle after dissection and before digestion with collagenase.
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Mice
Histological analysis of endochondral ossification.
Dissected specimens were fixed in 2% PFA at Immunofluorescence on tissue cultured cell specimens was performed with a method similar to that used for cryopreserved specimens. Briefly, cultured cells in 6-well to 96-well culture plates were washed with PBS and fixed in 2% PFA at 4°C overnight.
Specimens were treated with a blocking reagent, than probed with monoclonal antibody at 4°C overnight.
Paraformaldehyde fixed mouse bone marrow was labeled with anti-Thy1 (Santa Cruz) and biotinylated anti-6c3/BP-1 (eBiosciences) antibodies using a standard immunofluorescence staining protocol. After 3 rounds of washing with staining buffer, secondary antibodies were added. Specimens were next washed with PBS, probed with alexa-dye conjugated antibodies, washed, immersed in PBS, cover-slipped, and imaged with a the Zeiss LSM 510 Meta laser scanning confocal microscope. All images were analyzed using the NIH ImageJ software. Monoclonal antibody to mouse collagen II was purchased from NeoMarkers, monoclonal antibody to osteocalcin was purchased from Abcam. Alexa-dye conjugated secondary antibodies were purchased from Molecular Probes.
Cell culture.
Skeletal progenitors are cultured in vitro in MEM alpha medium with 20% FCS under low O 2 (2% atmospheric oxygen, 7.5% CO 2 ) conditions. Culture vessels were first coated with 0.1% gelatin. Cultured cells were lifted for analysis or passaging by incubating with M199 supplemented with 1mg/ml Collagenase II (Sigma) HSC-stromal co-culture and transplant.
To establish stromal populations for HSC co-culture experiments, 200,000 CD105+Thy1-6C3-CD45-Tie2-alphaV+ BCSPs were fresh-sorted from dissociated bone and bone marrow stroma of e15.5 dpc, e17.5 dpc, or newborn (post-natal day 0-3) mice, and plated on 0.1% gelatin coated 15-cm culture dish and supported with MEMalpha medium supplemented with 20%FCS and PenStrep (Invitrogen) antibiotic. Cells were cultured under low O 2 conditions (2% atmospheric oxygen, 7.5% CO 2 ). Two weeks after culture, cells were lifted by incubating with M199 medium supplemented with Collagenase II at 1mg/ml and then stained and FACs-sorted for indicated populations. A total of 5,000-10,000 cells of the indicated population were plated per well in 0.1 % gelatin-coated flatbottom 96-well dishes. Populations were cultured for 1 week before HSC co-culture. For HSC co-culture, wells plated with stromal cells were first washed with StemPro (StemCell.com) stem cell culture medium to remove serum. Then 250 fresh sorted HSCs were added to the stromal cells and co-cultured in StemPro serum-free stem cell culture media supplemented with 10 ng/ml mouse recombinant steel factor (Peprotech), 5 ng/ml mouse recombinant Thrompopoietin (Peprotech), 20ng/ml basic fibroblast growth factor (R&D), and 25 ng/ml insulin growth factor (R&D). Culture medium was changed by removing and replacing half of it with fresh medium every other day for 10 days. On the 10th day, cells were removed for analysis and or transplanted to irradiated mice. For HSC transplants, the contents of each well corresponding to approximately 250 plated HSCs were combined with 300,000 unsorted host bone marrow cells as helper marrow and injected retro-orbitally into lethally irradiated (800 rad) congenic mice. Engraftment was assessed by FACS analysis of tail blood samples collected at 5, 10, and 15 week intervals for analysis of expression of congenic CD45.1 or CD45.2 and blood lineagespecific markers-i.e., B-cell (B220+CD3-), T-cell (CD3+B220-), and granulocyte (B220-CD3-Gr1hi-ssc(hi)) markers.
For HSC co-culture with clonal BCSP-derived colonies, multipotent colonies, as illustrated in Fig. 4d , were established by clone-sorting e15.5 BCSPs into 0.1% gelatin coated flat-bottom 96-well plates. Colonies were allowed to grow for 3 weeks before HSC co-culture. Subsequently, 500 fresh-sorted HSCs were added to stromal colonies and co-cultured as described.
In vivo HSC tracking
For single HSC in vivo imaging and tracking, 15,000 RFP labeled HSCs were injected retro-orbitally into each GFP mouse and the bone marrow cavity were imaged within 5 hours of transplantation. The bone marrow window was prepared as previously described (1), and the mouse was immobilized onto the microscope stage using a custom-built platform to minimize micro-motion due to breathing and circulation. The mouse was kept alive on a heating pad and anesthesized via inhaled isofluorane. All imaging was done with a Prairie Ultima IV (Prarie Technologies, WI) upright in vivo twophoton microscope equipped with a 20X objective (N.A. 0.95). For the GFP channel, the emission filter used was 525±25 nm, and for RFP, the emission filter was 620±30 nm. All fluorophores were excited with a Ti:sapphire two-photon laser at an excitation wavelength of 900 nm (500 mW) (50) .
MicroCT imaging.
Anesthetized or newly sacrificed animals were imaged on a GE Medical Systems eXplore RS MicroCT System.
Nestin Intracellular FACS.
Limbs from post-natal day 3 mice were isolated and dissociated as described above.
Total dissociated cells were filtered through 40-um nylon mesh, pelleted at 200g at 4°C, resuspended in staining media (2% fetal calf serum in PBS), blocked with rat IgG, and stained with anti-mouse CD51 (clone RMV7) PE, anti-mouse CD45 (clone F30) PE-CY5, anti-mouse Ter119 PE-CY5, anti-mouse biotinylated CD105, anti-mouse 6C3, antimouse Tie2 (clone tek2) AlexaFluor680, and anti-mouse CD90.1 AlexaFluor 780. The secondary antibodies used were streptavidin PE-CY7 and goat anti-rat Quantum Dot 605. Following staining, propidium iodide was added and 100,000 cells from each of the specified populations was sorted on a BD FACS Aria II. The cells were then pelleted at 200g at 4°C and fixed in 2% parafomaldehyde for 1 hour at 4°C. Each population was permeabilized for 30 minutes with the detergent saponin and then stained with APC conjugated anti-mouse nestin (clone NESTIN) overnight at 4°C. A total of 10,000 events were then collected using a BD FACS Aria II.
Nestin-GFP FACS.
Femurs were harvested from 4-week old nestin-GFP transgenic mice. The marrow plug was flushed into collagenase buffer containing DNAse, using a 20-gauge needle. The remaining portion was minced in collagenase buffer using a razor blade. The marrow plug was placed in a 37°C incubator for 30 minutes. The minced cortical bone was digested at 37°C for 45 minutes under constant agitation. The cells were then triturated and passed through a 40-μm mesh filter. Dissociated cells were pelleted at 200g at 4°C, resuspended in staining media (2% fetal calf serum in PBS), blocked with rat IgG, and stained with fluorochrome-conjugated antibodies against CD45, Tie2, a V integrin, CD105, 6C3, and Thy1.1 for flow cytometric analysis.
Microarray analyses of BM Stromal progenitors.
We performed microarrays on BCSPs, Thy1+ cells, 6C3+ cells, and BLSPs. Each population was sorted in three independent sorts from limbs from 3-to 5-day-old male neonate. RNA was isolated with RNeasy Micro Kit (Qiagen) per manufacture's instructions. mRNA amplification was performed using a two-cycle target labeling system for 3' in vitro transcription, hybridized to a mouse genome 430 2.0 array, and scanned according to the manufacturer's protocol (Affymetrix). Background correction and signal normalization was performed using the standard multichip average algorithm (54) (55) .
